Published in Hepatology on June 01, 2010
Drug-induced autoimmune-like hepatitis. Dig Dis Sci (2011) 2.86
The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology (2011) 2.42
Acute and acute severe (fulminant) autoimmune hepatitis. Dig Dis Sci (2012) 2.08
Idiosyncratic adverse drug reactions: current concepts. Pharmacol Rev (2013) 1.12
Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease. World J Hepatol (2014) 1.11
Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases. Clin Gastroenterol Hepatol (2013) 1.10
Liver biopsy in the management of autoimmune hepatitis acute severe onset. Dig Dis Sci (2013) 1.05
An Update on Drug-induced Liver Injury. J Clin Exp Hepatol (2012) 1.01
Autoimmune hepatitis induced by adalimumab with successful switch to abatacept. Eur J Clin Pharmacol (2011) 0.95
Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review. Expert Rev Gastroenterol Hepatol (2015) 0.92
Drug-induced postinfantile giant cell hepatitis. Hepatology (2010) 0.89
Anastrozole-related acute hepatitis with autoimmune features: a case report. BMC Gastroenterol (2011) 0.88
Autoimmune hepatitis: a review. J Gastroenterol (2012) 0.86
Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury. Int J Mol Sci (2016) 0.85
Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury. Clin Gastroenterol Hepatol (2016) 0.84
Epidemiology and treatment of autoimmune hepatitis. Hepat Med (2012) 0.82
Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics. World J Gastroenterol (2015) 0.81
Drug Induced Liver Injury: Review with a Focus on Genetic Factors, Tissue Diagnosis, and Treatment Options. J Clin Transl Hepatol (2015) 0.80
Xenobiotic exposure and autoimmune hepatitis. Hepat Res Treat (2010) 0.80
Autoimmune hepatitis induced by nitrofurantoin. The importance of the autoantibodies for an early diagnosis of immune disease. Clin Pract (2012) 0.80
Autoimmune hepatitis as a unique form of an autoimmune liver disease: immunological aspects and clinical overview. Autoimmune Dis (2012) 0.79
Hepatitis mouse models: from acute-to-chronic autoimmune hepatitis. Int J Exp Pathol (2014) 0.79
Immunosuppressant therapy successfully improved regorafenib-induced severe hepatic injury in a patient with metastatic gastrointestinal stromal tumor: A case report. Oncol Lett (2015) 0.78
Autoimmune Hepatitis Triggered by Anti-TNF-α Therapy. Case Rep Med (2013) 0.78
Drug-induced autoimmune hepatitis caused by anti-tumor necrosis factor α agents. Hepatology (2010) 0.77
Transitioning from Idiopathic to Explainable Autoimmune Hepatitis. Dig Dis Sci (2015) 0.77
Seven cases of autoimmune hepatitis that developed after drug-induced liver injury. Hepatology (2011) 0.77
Nitrofurantoin immune-mediated drug-induced liver injury: a serious complication of a commonly prescribed medication. BMJ Case Rep (2014) 0.77
Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays. Biomed Res Int (2017) 0.76
Drug-induced autoimmune-like hepatitis: a case of chronic course after drug withdrawal. Dig Dis Sci (2011) 0.76
Drug-induced autoimmune-like hepatitis: a diagnostic challenge. Dig Dis Sci (2011) 0.76
Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor. J Hepatol (2017) 0.76
Comparison of Liver Biopsy Findings with the Digestive Disease Week Japan 2004 Scale for Diagnosis of Drug-Induced Liver Injury. Mediators Inflamm (2015) 0.75
Dichlorvos induced autoimmune hepatitis: a case report and review of literature. Hepat Mon (2015) 0.75
A Time to Pause and Reflect: When a Patient with Autoimmune Hepatitis Stops Responding to Corticosteroids. Case Rep Gastrointest Med (2016) 0.75
Drug-induced Liver Injury: The Hepatic Pathologist's Approach. Gastroenterol Clin North Am (2017) 0.75
Autoimmune hepatitis: current challenges and future prospects. Clin Exp Gastroenterol (2017) 0.75
Nitrofurantoin-induced microangiopathic haemolytic anaemia and thrombocytopaenia in a patient with systemic lupus erythematosus. BMJ Case Rep (2012) 0.75
Co-development of autoimmune hepatitis and Sjögren's syndrome triggered by the administration of herbal medicines. Clin Mol Hepatol (2013) 0.75
"Lupoid hepatitis" in SLE patients and mice with experimental lupus. Clin Immunol (2016) 0.75
Liraglutide-induced autoimmune hepatitis. JAMA Intern Med (2014) 0.75
Drug Induced Autoimmune Hepatitis by Amoxicillin-Clavulanate. Iran J Public Health (2016) 0.75
Toxin-Induced Autoimmune Hepatitis Caused by Raw Cashew Nuts. ACG Case Rep J (2016) 0.75
Extrahepatic Autoimmune Diseases in Patients with Autoimmune Liver Diseases: A Phenomenon Neglected by Gastroenterologists. Gastroenterol Res Pract (2017) 0.75
Drug-induced autoimmune hepatitis: an easily reversible type of liver fibrosis? Hepatology (2010) 0.75
Black Cohosh Hepatotoxicity with Autoimmune Hepatitis Presentation. Case Rep Gastroenterol (2017) 0.75
Autoimmune-like hepatitis during masitinib therapy in an amyotrophic lateral sclerosis patient. World J Gastroenterol (2015) 0.75
Drug-Induced Autoimmune Hepatitis following Treatment with Zoledronic Acid. Case Rep Gastroenterol (2017) 0.75
When Good Medications Go Bad, Don't DILI Dally. Dig Dis Sci (2016) 0.75
Auditory hallucinations associated with nitrofurantoin use: case report and review of the literature. Wien Klin Wochenschr (2014) 0.75
"Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis. Int J Mol Sci (2017) 0.75
Induced liver injury after high-dose methylprednisolone in a patient with multiple sclerosis. BMJ Case Rep (2015) 0.75
Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst (2008) 11.27
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology (2007) 6.68
Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med (2008) 6.67
Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med (2013) 5.19
Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol (2006) 4.70
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol (2005) 4.65
Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology (2007) 4.33
The Budd-Chiari syndrome. N Engl J Med (2004) 3.95
Acute-on chronic liver failure. J Hepatol (2012) 3.74
Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology (2002) 3.50
Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology (2010) 3.24
MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology (2005) 2.99
Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology (2003) 2.89
Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol (2007) 2.73
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology (2012) 2.69
EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest Endosc (2007) 2.61
Splanchnic artery aneurysms. Mayo Clin Proc (2007) 2.55
Retracted Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotherapy. J Clin Oncol (2010) 2.49
Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol (2005) 2.46
The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology (2011) 2.42
Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology (2007) 2.36
Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging. Radiology (2012) 2.35
Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). Medicine (Baltimore) (2006) 2.34
Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut (2010) 2.29
Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int (2012) 2.28
Current epidemiology of hepatitis E virus infection in the United States: low seroprevalence in the National Health and Nutrition Evaluation Survey. Hepatology (2014) 2.27
Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications. Hepatology (2008) 2.26
Utility of a new model to diagnose an alcohol basis for steatohepatitis. Gastroenterology (2006) 2.25
Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis. Am J Gastroenterol (2007) 2.15
Mesenteric venous thrombosis. Mayo Clin Proc (2013) 2.09
Outcome of second interventions for occluded metallic stents in patients with malignant biliary obstruction. Surg Endosc (2010) 2.07
A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol (2009) 2.06
Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology (2002) 2.04
A prospective evaluation of computerized tomographic (CT) scanning as a screening modality for esophageal varices. Hepatology (2008) 2.02
Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat Genet (2004) 1.96
Performance standards for therapeutic abdominal paracentesis. Hepatology (2004) 1.93
Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol (2011) 1.92
Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant (2004) 1.87
Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl (2007) 1.86
Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. Am J Physiol Gastrointest Liver Physiol (2011) 1.85
Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol (2007) 1.83
Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology (2014) 1.83
A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis. Am J Gastroenterol (2004) 1.83
Transjugular intrahepatic portosystemic shunts: an update. Liver Transpl (2003) 1.83
Hepatocellular carcinoma after the Fontan procedure. N Engl J Med (2013) 1.81
Peroral endoscopic drainage/debridement of walled-off pancreatic necrosis. Ann Surg (2007) 1.76
Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience. Hepatology (2012) 1.74
Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease. Hepatology (2008) 1.70
MR elastography of liver tumors: preliminary results. AJR Am J Roentgenol (2008) 1.69
Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut (2012) 1.67
A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology (2008) 1.65
Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology (2003) 1.65
Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management. Surgery (2012) 1.64
Serum sodium, renal function, and survival of patients with end-stage liver disease. J Hepatol (2010) 1.62
Histologic and imaging features of mural nodules in mucinous pancreatic cysts. Clin Gastroenterol Hepatol (2011) 1.61
Classification and expression analysis of Arabidopsis F-box-containing protein genes. Plant Cell Physiol (2002) 1.59
MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology (2004) 1.57
Septic shock secondary to scrub typhus: characteristics and complications. Southeast Asian J Trop Med Public Health (2002) 1.56
Prevalence, diagnosis, and profile of autoimmune pancreatitis presenting with features of acute or chronic pancreatitis. Clin Gastroenterol Hepatol (2009) 1.55
Intensive care of the patient with cirrhosis. Hepatology (2011) 1.54
Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand. Am J Trop Med Hyg (2003) 1.54
Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology (2011) 1.49
Patients with typical laboratory features of autoimmune hepatitis rarely need a liver biopsy for diagnosis. Clin Gastroenterol Hepatol (2010) 1.48
Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease. Am J Hum Genet (2003) 1.47
A comparison of direct endoscopic necrosectomy with transmural endoscopic drainage for the treatment of walled-off pancreatic necrosis. Gastrointest Endosc (2009) 1.47
ydk1-D, an auxin-responsive GH3 mutant that is involved in hypocotyl and root elongation. Plant J (2004) 1.46
Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature. Hepatology (2007) 1.45
Significance of nodular regenerative hyperplasia occurring de novo following liver transplantation. Liver Transpl (2007) 1.39
Medical and surgical treatment options for polycystic liver disease. Hepatology (2010) 1.39
Somatic and visceral solitary fibrous tumors in the abdomen and pelvis: cross-sectional imaging spectrum. Radiographics (2011) 1.38
Recurrent idiopathic hepatitis: a new entity? J Clin Gastroenterol (2003) 1.38
Clinical profile of autosomal dominant polycystic liver disease. Hepatology (2003) 1.37
Feasibility of in vivo MR elastographic splenic stiffness measurements in the assessment of portal hypertension. AJR Am J Roentgenol (2009) 1.37
New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology (2013) 1.35
Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol (2008) 1.35
Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis. J Gastroenterol Hepatol (2002) 1.33
Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2013) 1.33
Acute-on-chronic liver failure: concept, natural history, and prognosis. Curr Opin Crit Care (2011) 1.33
Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. Mayo Clin Proc (2003) 1.30
Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease. Liver Int (2005) 1.27
Dual-energy and dual-source CT: is there a role in the abdomen and pelvis? Radiol Clin North Am (2009) 1.27
Non-contrast renal artery MRA using an inflow inversion recovery steady state free precession technique (Inhance): comparison with 3D contrast-enhanced MRA. J Magn Reson Imaging (2010) 1.26
Acute superior mesenteric venous thrombosis: one disease or two? Am J Gastroenterol (2003) 1.24
Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease. Hepatology (2009) 1.21
Renal epithelioid angiomyolipoma: imaging characteristics in nine cases with radiologic-pathologic correlation and review of the literature. AJR Am J Roentgenol (2013) 1.19
Multicenter phase II study of bendamustine plus rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma. J Clin Oncol (2013) 1.17
Impaired motor coordination in mice lacking neural recognition molecule NB-3 of the contactin/F3 subgroup. J Neurobiol (2003) 1.17
Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer. Ann Nucl Med (2005) 1.17
Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology (2014) 1.16
A series of luminescent Cu(I) mixed-ligand complexes containing 2,9-dimethyl-1,10-phenanthroline and simple diphosphine ligands. Dalton Trans (2006) 1.16
Imaging of the seminal vesicle and vas deferens. Radiographics (2009) 1.15
A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury. J Am Med Inform Assoc (2013) 1.14
Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure? Clin Gastroenterol Hepatol (2004) 1.14